logo

Impact of Unethical Business Practices on the Success of Sackler Family and OxyContin

   

Added on  2023-01-18

8 Pages2385 Words77 Views
 | 
 | 
 | 
Sakler Family and
OXYContin
Impact of Unethical Business Practices on the Success of Sackler Family and OxyContin_1

TABLE OF CONTENT
INTRODUCTION...........................................................................................................................1
ANALYSIS .....................................................................................................................................1
Success in terms of revenue and influence of unethical behaviour ............................................1
Perspective of different ownership members from Sackler family towards success .................2
Success from board perspective ..................................................................................................3
Success from perspective of public confidence ..........................................................................4
CONCLUSION ...............................................................................................................................5
RECOMMENDATIONS ................................................................................................................5
Impact of Unethical Business Practices on the Success of Sackler Family and OxyContin_2

INTRODUCTION
Business law and ethical principles are defined as the moral and legislative regulations
which govern the business practices. These principles ensures that all actions and decisions taken
by the firm are for the welfare of community and does not cause any harm to people. The success
can be defined as the accomplishment of organisational goals in terms of profitability, financial
gains, customer satisfaction, quality of services, ethics and legislative context (Sison, Beabout
and Ferrero, 2017). The negligence of ethics can make the success of organisation short term and
incomplete.
The study will discuss the case study of Sackler family which has been accused of
misconduct in various business practices such as marketing and promotion. Sackler family owns
Purdue pharma which has been facing legal suits against highly addictive opioid drug
OxyContin. Despite evidences of deaths and addictions, organisation followed aggressive and
manipulative marketing. This has deteriorated the brand value and success of organisation to
great extent. Sackler family has been facing huge criticism all over world for their unethical
practices. Thus the report will discuss the impact of unethical business practices on business
success. It will also provides an evaluation that how organisational success can be measured and
perceived from different perspectives.
ANALYSIS
Success in terms of revenue and influence of unethical behaviour
Sackler family conducted unethical practices at various stages of their business. For
instance when their controversial addictive drug OxyContin was launched organisation used to
pay all expenses of medical professionals so that their decision can be influenced. Similarly in
marketing, budget, public feedbacks and audits also all records and indications of unethical
behaviour were discarded (Ferrell and Fraedrich, 2015). These practices influences
organisational success financially. The OxyContin drug of Purdue pharma has been facing legal
challenges in 45 US states and in nearly 1500 cities. In addition to this Sackler family has been
ID: 1918080/1
1
Impact of Unethical Business Practices on the Success of Sackler Family and OxyContin_3

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Unethical Behavior of Sackler Family and Purdue Pharma
|8
|2233
|89

Current Trends Of Unethical Behavior Within Organizations
|9
|2744
|122

The Sackler Family Business: Unethical Practices and Consequences
|10
|2737
|66

Academic and Professional Skills
|8
|2220
|59

Museum and Galleries Supported by the Sackler Family
|9
|2556
|90

Impact of Unethical Behavior on Business Success: A Case Study of Sackler Family and OxyContin
|9
|2694
|75